New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
08:05 EDTDXCMDexCom price target raised to $44 from $34 at Canaccord
Canaccord said DexCom's preliminary Q4 results were strong and demonstrate the market-expanding potential for the next-gen Gen4 Platinum sensor. Shares are Buy rated.
News For DXCM From The Last 14 Days
Check below for free stories on DXCM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
10:00 EDTDXCMOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:50 EDTDXCMDexCom upgraded at Sterne Agee
As noted earlier, Sterne Agee upgraded DexCom to Buy from Neutral. The firm expects the company to generate strong annual revenue growth, and believes that use of its G4 Platinum product will become more widespread after the FDA approved it for people ages 2-17. Target $50.
05:54 EDTDXCMDexCom upgraded to Buy from Neutral at Sterne Agee
Price target is $50.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use